Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituximab in Life Threatening Therapy Resistant Progressive Interstitial Pneumonitis

NCT02251964 is registered in ClinicalTrials.gov with Human Adams as lead sponsor.

NCT NCT02251964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02251964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituximab in Life Threatening Therapy Resistant Progressive Interstitial Pneumonitis
Lead sponsor
Human Adams
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2014
Completion date
February 28, 2018
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung diseases, interstitial, pneumonitis, interstitial